# Effects of Pitavastatin on Insulin Sensitivity and Liver Fat

> **NCT02290106** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 50 (actual)

## Conditions studied

- Obesity
- Fatty Liver, Nonalcoholic

## Interventions

- **DRUG:** pitavastatin
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT02290106
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-02
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02290106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02290106, "Effects of Pitavastatin on Insulin Sensitivity and Liver Fat". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02290106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*